CASP vs Hepatocellular Carcinoma
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CASP
Critically appraise medical literature using evidence-based templates. Includes a glossary, calculators for NNT and post-test probability, and the ability to save and share appraisals.
- Critical appraisal templates
- Glossary of terms
- NNT calculator
- Post-Test Probability calculator
- Save and share appraisals
- PDF export
Read full descriptionHide full description
CASP offers a convenient way to critically apprais the medical literature, it is based in CASP (Critical Appraisal Skills Programme) templates. And incorporates a Glossary section, and NNT and Post-Test Probability calculators with interpretation of the results. It allows to save and share critical appraisals in CASP and PDF formats.
Hepatocellular Carcinoma
Read full descriptionHide full description
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Hepatocellular Carcinoma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Hepatocellular Carcinoma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Hepatocellular Carcinoma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
Screenshots
Verdict
The clearest difference is iOS requirement: CASP at 7.0 against Hepatocellular Carcinoma's 14.0. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on November 1, 2026 and November 11, 2026 respectively.
| Parameter | CASP | Hepatocellular Carcinoma |
|---|---|---|
| Price | Free | Free |
| Rating | 2.5 (2 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 2 — better | — |
| Update frequency | Every 2 months | Every 2 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 7.0 — better | 14.0 |
| Further details — not scored | ||
| Size | 2 MB | 23 MB |
| Age rating | 4+ | 12+ |
| Developer | Luis Ruiz del Fresno | @Point of Care |
In-app purchases
CASP
No in-app purchases
Hepatocellular Carcinoma
No in-app purchases
Questions
Is CASP free?
Is Hepatocellular Carcinoma free?
Do CASP or Hepatocellular Carcinoma have ads?
Which is updated more often, CASP or Hepatocellular Carcinoma?
Other comparisons















